Category

Cohort News

All Posts StratifiCare Unveils Promising Results of StratifiREY Radioembolization Effectiveness Prediction Test for Liver Cancer at SEA & ANZ Beckman Coulter User Group Meeting

//
Categories
StratifiCare is proud to announce the presentation of StratifiREY, our AI-powered blood test that predicts liver cancer patients’ response to yttrium-90 radioembolization (Y90-RE), at the recent SEA & ANZ CytoFLEX User Group Meeting hosted by Beckman Coulter Life Sciences. Our...
Read More →